AbbVie Inc. (NYSE:ABBV) announced positive results on Monday, for its two direct-acting antiviral treatment (2-DAA) in a Phase III study trial for patients suffering from genotype 1b chronic (GT1b) hepatitis C virus (HCV). 2-DAA is an all-oral and ribavirin (RBV)-free treatment. It is formed through a fixed-dose combination of paritaprevir/ritonavir (150/100 mg) with ombitasvir (25 mg) to be taken once daily. Paritaprevir is a lead protease inhibitor of Enanta Pharmaceuticals Inc. (NASDAQ:ENTA), discovered under the collaboration between Enanta and AbbVie, for which AbbVie had developing and commercializing rights. On Tuesday shares of AbbVie Inc. (NYSE:ABBV) closed at $61.65. Company’s EPS growth for next 5 years is recorded as 15.40%.
Medtronic plc (NYSE:MDT) announced the initiation of the Cryo4 Persistent AF (Cryoballoon Ablation for Early Persistent Atrial Fibrillation) clinical trial. The trial will evaluate the 12-month clinical outcomes of cryoballoon ablation for isolating the pulmonary veins without additional ablation strategies using the Medtronic Arctic Front AdvanceTMCryoballoon system to treat patients with early persistent atrial fibrillation (AF). Medtronic plc (NYSE:MDT) in last trading activity advanced 2.79% to close at $74.79. Company weekly performance is -0.62% while its quarterly performance stands at 10.18%. Medtronic plc (NYSE:MDT) is -3.36% away from its 52 week high.
MaxLinear Inc (NYSE:MXL) has acquired Entropic Communications, a maker of semiconductor solutions for the connected home. The all-stock deal is valued at $287 million, with Entropic shareholders receiving $1.20 per share in cash and 0.2200 shares of MaxLinear common stock for each Entropic common share outstanding. The transaction is expected to close in the second quarter. On last trading day MaxLinear, Inc. (NYSE:MXL) advanced 3.40% to close at $8.52. Its volatility for the week is 4.14% while volatility for the month is 3.97%. MXL’s sales growth for past 5 years was 30.70% and its EPS growth for past 5 years was -14.30%. MaxLinear, Inc. (NYSE:MXL) monthly performance is 14.21%.
BorgWarner Inc. (NYSE:BWA) announces the Webcast: BorgWarner 2014 Fourth Quarter and Full Year Results Conference Call, will held on February 12 @ 9:30am Eastern. BorgWarner Inc. (NYSE:BWA) has 0.10% insider ownership while its institutional ownership stands at 91.20%. In last trading activity company’s stock closed at $57.03.
Ocean Power Technologies Inc (NASDAQ:OPTT) COO David R. Heinz purchased 20,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 20th. The shares were purchased at an average cost of $0.52 per share, with a total value of $10,400.00. On last trading day Ocean Power Technologies, Inc. (NASDAQ:OPTT) advanced 19.51% to close at $0.49. Its volatility for the week is 19.24% while volatility for the month is 13.50%. OPTT’s sales growth for past 5 years was -17.80% and its EPS growth for past 5 years was 12.70%. Ocean Power Technologies, Inc. (NASDAQ:OPTT) monthly performance is -24.62%.